Biomarkers Improve Clinical Outcome Predictors of Mortality Following Non-Penetrating Severe Traumatic Brain Injury

Overview of attention for article published in Neurocritical Care, July 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 78 Mendeley

Summary Patents Facebook Dimensions citations

So far, Dimensions has found 54 publications that cite this research output.

54

The most recent citing publications are shown below. View all 54 publications that cite this research output on Dimensions.

The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury

Article in Expert Review of Molecular Diagnostics (January 2024)

Post-mortem detection of neuronal and astroglial biochemical markers in serum and urine for diagnostics of traumatic brain injury

Article in International Journal of Legal Medicine (June 2023)

Diagnostic performance of point-of-care ubiquitin carboxy-terminal Hydrolase-L1 assay in distinguishing imaging abnormalities in traumatic brain injury: A TRACK-TBI cohort study

Article in Advances in Biomarker Sciences and Technology (January 2023)